A Study of CI-1012 in HIV-Infected Patients

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

NCT00002035 ·Status: COMPLETED ·Phase: NA

The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine

NCT00002312 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

NCT00143624 ·Status: COMPLETED ·Phase: NA

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA

Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults

NCT03408899 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

NCT04334915 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

NCT00113412 ·Status: UNKNOWN ·Phase: PHASE2

Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults

NCT03393468 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Patients Who Have Not Had Success With Zidovudine

NCT00001025 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of 524W91

NCT00002335 ·Status: COMPLETED ·Phase: PHASE1

A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

NCT00002337 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

NCT00002111 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

NCT00016692 ·Status: TERMINATED ·Phase: PHASE1

Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)

NCT00000765 ·Status: COMPLETED ·Phase: NA

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus

NCT00361101 ·Status: COMPLETED ·Phase: PHASE1

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

NCT00000823 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

NCT00110591 ·Status: COMPLETED ·Phase: PHASE1

Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.

NCT02206711 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

NCT00000792 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

NCT02033109 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

NCT00002097 ·Status: COMPLETED ·Phase: PHASE1

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

NCT00002094 ·Status: COMPLETED ·Phase: NA

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

NCT00000812 ·Status: COMPLETED ·Phase: PHASE1

MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

NCT03570918 ·Status: COMPLETED ·Phase: PHASE1